Similarly , the pooled bioactive stent group was associated with a risk ratio of @ for cardiac death ( @ % confidence interval , @-@ @ ; P = @ ) , @ for recurrent myocardial infarction ( @ % confidence interval , @-@ @ ; P = @ ) , and @ for ischemia-driven target lesion revascularization ( @ % confidence interval , @-@ @ ; P = @ ) , compared to the pooled drug-eluting stent group .